Health
ERS Genomics Appoints Michael Arciero As Vice-President of Intellectual Property & Commercial Development – Technology Networks
Michael previously led the technology transfer team at USC Stevens Center for Innovation in his capacity as Director of Technology Commercialisation.
ERS Genomics Limited (ERS), which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property (IP) co-owned by Dr. Emmanuelle Charpentier, today announced the appointment of Michael Arciero as Vice-President of Intellectual Property and Commercial Development. In the new role, Michael will oversee the intellectual property portfolio of the company and will become a core member of the Company’s global business development team.Michael has over 15 years of experience i…
-
Business20 hours agoIs Warren Buffett’s Berkshire Hathaway the smartest investment you can make today?
-
General21 hours agoTop chess player Magnus Carlsen forced into draw in historic game against over 134,000 people
-
General20 hours agoTaiwan’s President Lai Ching-te calls for peace and dialogue with China while also calling for defence boosts
-
Noosa News13 hours agoThe Trailer for ‘The Bear’ Season Four Is Here — and It’s Cooking Up a Race to Keep Carmy and Syd’s Restaurant Running